Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Colorcon
Dow
Baxter
AstraZeneca

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation Details for TEVA WOMEN'S HEALTH, INC. v. MYLAN PHARMACEUTICALS, INC. (D.N.J. 2010)

See Plans and Pricing

« Back to Dashboard

TEVA WOMEN'S HEALTH, INC. v. MYLAN PHARMACEUTICALS, INC. (D.N.J. 2010)

Docket   Start Trial Date Filed 2010-03-09
Court District Court, D. New Jersey Date Terminated 2010-11-30
Cause 35:271 Patent Infringement Assigned To Peter G. Sheridan
Jury Demand None Referred To Esther Salas
Parties FAMY CARE LTD.; MYLAN PHARMACEUTICALS, INC.; MYLAN, INC.; TEVA WOMEN'S HEALTH, INC.
Patents 5,108,995; 5,208,225; 5,552,394; 5,898,032; 7,320,969; RE36,247
Attorneys ARNOLD B. CALMANN; GERI L. ALBIN; MICHAEL E. PATUNAS
Link to Docket External link to docket
Small Molecule Drugs cited in TEVA WOMEN'S HEALTH, INC. v. MYLAN PHARMACEUTICALS, INC.

Details for TEVA WOMEN'S HEALTH, INC. v. MYLAN PHARMACEUTICALS, INC. (D.N.J. 2010)

Date Filed Document No. Description Snippet Link To Document
2010-03-09 1 quot; Contracqztion 44:107-112, Butta'worth- 5,108,995 A 4/1992 casper H°m°'w“‘ (1991)~ 5,208,225…of that patent. A copy of the ‘969 Patent is attached hereto as Exhibit A. 13. The ‘969 Patent is directed… United States Patent (10) Patent No.: US 7,320,969 B2 Bell et al. (45) Date of Patent: Jan. 22, 2008 … This i`s a civil action for patent infringement arising under the Patent Laws of the United States, …United States Patent and Trademark Office (“USPTO”) duly and legally issued U.S. Patent No. 7,320,969 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
McKesson
Dow
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.